Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats.
D000818:Animals; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors; D001794:Blood Pressure / Q000187:drug effects; D004837:Epinephrine / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D007546:Isoquinolines / Q000494:pharmacology; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives; D000077555:Methylprednisolone Acetate; D009638:Norepinephrine / Q000097:blood; D010625:Phenylethanolamine N-Methyltransferase / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D012504:Saralasin / Q000494:pharmacology; D044005:Tetrahydroisoquinolines; D014661:Vasoconstriction
D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D001127:Arginine Vasopressin; D000077555:Methylprednisolone Acetate; C012153:7,8-dichloro-1,2,3,4-tetrahydroisoquinoline; D010625:Phenylethanolamine N-Methyltransferase; D012504:Saralasin; D009638:Norepinephrine; D008775:Methylprednisolone; D004837:Epinephrine